Jean-Pierre Hubschman
CEO

Horizon Surgical Systems develops assistive surgical robotics platforms, such as Polaris™, specifically engineered for ophthalmic procedures like cataract surgery. This technology integrates real-time 3D imaging, machine learning, and microsurgical dexterity to enhance surgeon performance and standardize surgical outcomes. The platform aims to improve the consistency and accessibility of high-quality vision restoration procedures for a growing patient population.
Raised to date
$51MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
$30M across 1 disclosed round

MSUI$30M · Series A
Announced Oct 2024
Disclosed cumulative: $30M
Reported total $51M
Incomplete round history. $21M of the $51M reported total isn’t matched to a known round.
Microsurgery in ophthalmology demands extreme precision, often exceeding the limits of human dexterity and endurance, which can lead to suboptimal outcomes and complications. The availability of highly skilled surgeons is limited, creating bottlenecks in access to advanced eye care.
Horizon Surgical Systems is developing Polaris, an AI-driven, imaging-guided surgical robotics platform designed to enhance precision and expand the capabilities of surgeons during microsurgical procedures in ophthalmology. Polaris integrates state-of-the-art robotics, advanced medical imaging, and artificial intelligence to provide surgeons with enhanced control, visualization, and real-time feedback. The system aims to improve surgical outcomes, reduce complications, and increase access to specialized eye care by extending the reach of skilled surgeons.
The primary target audience includes ophthalmologists, hospitals, and surgical centers specializing in advanced eye care and seeking to improve surgical precision, outcomes, and access to care.